Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Lymphocytic, Acute, L2”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableEnded earlyNCT01761682
What this trial is testing

Acute Lymphoblastic Leukemia Registry at Asan Medical Center

Who this might be right for
Leukemia, Acute LymphoblasticPrecursor B-Cell Lymphoblastic LeukemiaLeukemia, Biphenotypic, Acute+2 more
Asan Medical Center 200
Not applicableStudy completedNCT00049569
What this trial is testing

Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
L1 Childhood Acute Lymphoblastic LeukemiaL2 Childhood Acute Lymphoblastic LeukemiaNon-T, Non-B Childhood Acute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 126
Early research (Phase 1)Ended earlyNCT00500006
What this trial is testing

A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)

Who this might be right for
Chronic Myelogenous LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Merck Sharp & Dohme LLC 3
Large-scale testing (Phase 3)Study completedNCT00002812
What this trial is testing

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 2,078
Testing effectiveness (Phase 2)Study completedNCT04554485
What this trial is testing

Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Lymphoblastic Leukemia, Acute, AdultPh Negative ALLNewly Diagnosed
Institute of Hematology and Blood Transfusion, Czech Republic 27
Large-scale testing (Phase 3)UnknownNCT00003728
What this trial is testing

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
European Organisation for Research and Treatment of Cancer - EORTC 1,500
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Large-scale testing (Phase 3)Study completedNCT00005945
What this trial is testing

Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 3,054
Testing effectiveness (Phase 2)Study completedNCT01310010
What this trial is testing

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 30
Early research (Phase 1)Study completedNCT00005593
What this trial is testing

Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Case Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)UnknownNCT05429905
What this trial is testing

Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia

Who this might be right for
Lymphoblastic LeukemiaLymphoblastic Leukemia, Acute, ChildhoodLymphoblastic Leukemia in Children+2 more
KK Women's and Children's Hospital 48
Early research (Phase 1)Ended earlyNCT00907517
What this trial is testing

Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)

Who this might be right for
Myelogenous Leukemia, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Lymphoblastic, Acute, Philadelphia-Positive+1 more
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Looking for participantsNCT05043571
What this trial is testing

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LeukemiaLymphoblastic Leukemia, Acute Adult+4 more
National University Hospital, Singapore 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07387926
What this trial is testing

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00006020
What this trial is testing

S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 35
Testing effectiveness (Phase 2)Study completedNCT00006008
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00337168
What this trial is testing

S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 36
Large-scale testing (Phase 3)WithdrawnNCT00019409
What this trial is testing

Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Load More Results